More than 130 human health companies are in SOSV's portfolio, and more than 30 of those are pre-series-A biopharma start-ups in IndieBio's program. Mohan Iyer is a General Partner at SOSV’s IndieBio San Francisco. He brings deep operational experience with over 25+ years as an entrepreneur and leader at several life science startups where he enjoyed developing strategy, building successful teams, executing against complex operational goals, fundraising in good times and bad, and forging creative sell-side strategic partnering and M&A deals. Having walked in these shoes, he is passionate about serving genius entrepreneurs to realize their mission of a better world by creating, scaling, and exiting meaningful new companies. This session features an in-depth conversation with a highly active investor in seed-stage biopharmas regarding the current economic environment for private biopharma investment and opportunities for early-stage companies.